• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌酵母CNCM I-745通过改变细胞外基质组成抑制体外生物膜形成。

Inhibition of In Vitro Biofilm Formation by the Probiotic Yeast CNCM I-745 through Modification of the Extracellular Matrix Composition.

作者信息

Lacotte Pierre-Alexandre, Simons Alexis, Bouttier Sylvie, Malet-Villemagne Jeanne, Nicolas Valérie, Janoir Claire

机构信息

INRAE, Université Paris-Saclay, AgroParisTech, Micalis Institute, 92290 Châtenay-Malabry, France.

Laboratoire Eau, Environnement et Systèmes Urbains (Leesu), Université Paris-Est Créteil, École des Ponts ParisTech, 94010 Créteil, France.

出版信息

Microorganisms. 2022 May 24;10(6):1082. doi: 10.3390/microorganisms10061082.

DOI:10.3390/microorganisms10061082
PMID:35744599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9227484/
Abstract

is responsible for post-antibiotic diarrhea and most of the pseudomembranous colitis cases. Multiple recurrences, one of the major challenges faced in infection (CDI) management, can be considered as chronic infections, and the role of biofilm formation in CDI recurrences is now widely considered. Therefore, we explored if the probiotic yeast CNCM I-745 could impact the in vitro formation of biofilm. Biomass staining and viable bacterial cell quantification showed that live exerts an antagonistic effect on the biofilm formation for the three strains tested. Confocal laser scanning microscopy observation revealed a weakening and an average thickness reduction of the biofilm structure when is co-incubated with , compared to the single-species bacterial biofilm structure. These effects, that were not detected with another genetically close yeast, , seemed to require direct contact between the probiotic yeast and the bacterium. Quantification of the extrapolymeric matrix components, as well as results obtained after DNase treatment, revealed a significant decrease of eDNA, an essential structural component of the biofilm matrix, in the dual-species biofilm. This modification could explain the reduced cohesion and robustness of biofilms formed in the presence of CNCM I-745 and be involved in clinical preventive effect against CDI recurrences.

摘要

它是抗生素相关性腹泻和大多数伪膜性结肠炎病例的病因。多次复发是艰难梭菌感染(CDI)管理面临的主要挑战之一,可被视为慢性感染,生物膜形成在CDI复发中的作用现在已得到广泛认可。因此,我们探究了益生菌酵母CNCM I-745是否会影响生物膜的体外形成。生物量染色和活菌细胞定量分析表明,活菌对所测试的三种菌株的生物膜形成具有拮抗作用。共聚焦激光扫描显微镜观察显示,与单菌种细菌生物膜结构相比,当与[具体菌株]共同孵育时,生物膜结构减弱且平均厚度减小。这些效应在另一种亲缘关系较近的酵母[具体酵母]中未检测到,似乎需要益生菌酵母与细菌直接接触。对胞外聚合物基质成分的定量分析以及DNase处理后获得的结果表明,在双菌种生物膜中,胞外DNA(生物膜基质的一种重要结构成分)显著减少。这种改变可以解释在存在CNCM I-745的情况下形成的生物膜凝聚力和坚固性降低的原因,并可能参与对CDI复发的临床预防作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c38/9227484/898b3013ddc1/microorganisms-10-01082-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c38/9227484/bdde8a5d0db0/microorganisms-10-01082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c38/9227484/938d02c75aff/microorganisms-10-01082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c38/9227484/94aff747f56b/microorganisms-10-01082-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c38/9227484/8da2b4fea165/microorganisms-10-01082-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c38/9227484/c7a59cc71133/microorganisms-10-01082-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c38/9227484/9f76ae93a579/microorganisms-10-01082-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c38/9227484/898b3013ddc1/microorganisms-10-01082-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c38/9227484/bdde8a5d0db0/microorganisms-10-01082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c38/9227484/938d02c75aff/microorganisms-10-01082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c38/9227484/94aff747f56b/microorganisms-10-01082-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c38/9227484/8da2b4fea165/microorganisms-10-01082-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c38/9227484/c7a59cc71133/microorganisms-10-01082-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c38/9227484/9f76ae93a579/microorganisms-10-01082-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c38/9227484/898b3013ddc1/microorganisms-10-01082-g007.jpg

相似文献

1
Inhibition of In Vitro Biofilm Formation by the Probiotic Yeast CNCM I-745 through Modification of the Extracellular Matrix Composition.益生菌酵母CNCM I-745通过改变细胞外基质组成抑制体外生物膜形成。
Microorganisms. 2022 May 24;10(6):1082. doi: 10.3390/microorganisms10061082.
2
The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.布拉氏酵母菌预防治疗对频繁使用易致艰难梭菌感染抗生素的住院患者艰难梭菌医院感染发病率的影响。
Clin Infect Dis. 2021 Nov 2;73(9):e2512-e2518. doi: 10.1093/cid/ciaa808.
3
Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters.益生菌布拉酵母菌CNCM I-745可预防仓鼠中与暴发相关的艰难梭菌相关性盲肠炎。
Am J Physiol Gastrointest Liver Physiol. 2016 Oct 1;311(4):G610-G623. doi: 10.1152/ajpgi.00150.2016. Epub 2016 Aug 11.
4
Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases.布拉酵母菌CNCM I-745:一种用作益生菌剂辅助治疗特定疾病的非细菌微生物。
Curr Microbiol. 2020 Sep;77(9):1987-1996. doi: 10.1007/s00284-020-02053-9. Epub 2020 May 29.
5
Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review.酵母益生菌布拉酵母菌CNCM I-745的独特特性:一篇叙述性综述。
Cureus. 2023 Oct 1;15(10):e46314. doi: 10.7759/cureus.46314. eCollection 2023 Oct.
6
Saccharomyces boulardii prophylaxis for targeted antibiotics and infectious indications to reduce healthcare facility-onset Clostridioides difficile infection.布拉氏酵母菌预防治疗用抗生素和感染性指征以降低医疗机构获得性艰难梭菌感染。
Microbes Infect. 2023 Mar-Apr;25(3):105041. doi: 10.1016/j.micinf.2022.105041. Epub 2022 Sep 1.
7
Prevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic review.布拉氏酵母菌预防艰难梭菌感染:一项系统评价
Can J Gastroenterol. 2009 Dec;23(12):817-21. doi: 10.1155/2009/915847.
8
[Saccharomyces boulardii CNCM I-745 - the medicinal yeast improves intestinal enzyme function].[布拉酵母菌CNCM I-745——这种药用酵母可改善肠道酶功能]
MMW Fortschr Med. 2019 Mar;161(Suppl 4):20-24. doi: 10.1007/s15006-019-0290-5. Epub 2019 Mar 20.
9
Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.布拉氏酵母菌蛋白酶可抑制艰难梭菌毒素A对大鼠回肠的作用。
Infect Immun. 1996 Dec;64(12):5225-32. doi: 10.1128/iai.64.12.5225-5232.1996.
10
A probiotic yeast-based immunotherapy against infection.一种基于益生菌酵母的抗感染免疫疗法。
Sci Transl Med. 2020 Oct 28;12(567). doi: 10.1126/scitranslmed.aax4905.

引用本文的文献

1
Extracellular DNA filaments associated with surface polysaccharide II give Clostridioides difficile biofilm matrix a network-like structure.与表面多糖II相关的细胞外DNA细丝赋予艰难梭菌生物膜基质一种网络状结构。
NPJ Biofilms Microbiomes. 2025 Jun 13;11(1):108. doi: 10.1038/s41522-025-00751-5.
2
Probiotic Saccharomyces boulardii Against Cronobacter sakazakii Infection: In Vitro and In Vivo Studies.益生菌布拉氏酵母菌抗阪崎肠杆菌感染的体外和体内研究
Probiotics Antimicrob Proteins. 2025 Mar 21. doi: 10.1007/s12602-025-10524-3.
3
Clostridioides difficile Biofilm.

本文引用的文献

1
reduces the extracellular matrix components of fluconazole-susceptible biofilms.减少氟康唑敏感生物膜的细胞外基质成分。
Biofouling. 2021 Oct-Nov;37(9-10):1006-1021. doi: 10.1080/08927014.2021.2001645. Epub 2021 Nov 18.
2
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.欧洲临床微生物学和传染病学会:成人艰难梭菌感染治疗指南的 2021 年更新。
Clin Microbiol Infect. 2021 Dec;27 Suppl 2:S1-S21. doi: 10.1016/j.cmi.2021.09.038. Epub 2021 Oct 20.
3
Wolf in Sheep's Clothing: Biofilm as a Reservoir for Recurrent Infections.
艰难梭菌生物膜。
Adv Exp Med Biol. 2024;1435:249-272. doi: 10.1007/978-3-031-42108-2_12.
4
Potential benefits of yeast and their derivatives in dogs and cats: a review.酵母及其衍生物对犬猫的潜在益处:综述
Front Vet Sci. 2023 Oct 25;10:1279506. doi: 10.3389/fvets.2023.1279506. eCollection 2023.
5
Resistance, Tolerance, Virulence and Bacterial Pathogen Fitness-Current State and Envisioned Solutions for the Near Future.抗性、耐受性、毒力与细菌病原体适应性——当前状况及对近期未来的设想解决方案
Pathogens. 2023 May 22;12(5):746. doi: 10.3390/pathogens12050746.
6
Whole-Genome Analysis of CC-PT4 against MRSA, a Non- Yeast Isolated from Grape.从葡萄中分离出的非酵母CC-PT4对耐甲氧西林金黄色葡萄球菌的全基因组分析。
J Fungi (Basel). 2022 Nov 28;8(12):1255. doi: 10.3390/jof8121255.
7
DNase inhibits early biofilm formation in - or -induced empyema models.DNase 抑制 - 或 - 诱导的脓胸模型中的早期生物膜形成。
Front Cell Infect Microbiol. 2022 Oct 12;12:917038. doi: 10.3389/fcimb.2022.917038. eCollection 2022.
披着羊皮的狼:作为复发性感染储存库的生物膜
Microorganisms. 2021 Sep 10;9(9):1922. doi: 10.3390/microorganisms9091922.
4
Epidemiology of community-acquired and recurrent infection.社区获得性感染和复发性感染的流行病学
Therap Adv Gastroenterol. 2021 May 22;14:17562848211016248. doi: 10.1177/17562848211016248. eCollection 2021.
5
Clostridioides difficile biofilms: A mechanism of persistence in the gut?艰难梭菌生物膜:肠道内的一种持续存在机制?
PLoS Pathog. 2021 Mar 11;17(3):e1009348. doi: 10.1371/journal.ppat.1009348. eCollection 2021 Mar.
6
Extracellular DNA, cell surface proteins and c-di-GMP promote biofilm formation in Clostridioides difficile.细胞外 DNA、细胞表面蛋白和 c-di-GMP 促进艰难梭菌生物膜的形成。
Sci Rep. 2021 Feb 5;11(1):3244. doi: 10.1038/s41598-020-78437-5.
7
Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection.生物膜中藏匿着艰难梭菌,是导致复发感染的储菌库。
NPJ Biofilms Microbiomes. 2021 Feb 5;7(1):16. doi: 10.1038/s41522-021-00184-w.
8
The Use of Probiotics to Fight Biofilms in Medical Devices: A Systematic Review and Meta-Analysis.益生菌用于对抗医疗器械中的生物膜:一项系统评价与荟萃分析
Microorganisms. 2020 Dec 23;9(1):27. doi: 10.3390/microorganisms9010027.
9
Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020.系统评价:2000 年至 2020 年粪便微生物群移植相关不良事件的全球发生率。
Aliment Pharmacol Ther. 2021 Jan;53(1):33-42. doi: 10.1111/apt.16148. Epub 2020 Nov 7.
10
Biofilm Matrixome: Extracellular Components in Structured Microbial Communities.生物膜基质组学:结构化微生物群落中的细胞外成分。
Trends Microbiol. 2020 Aug;28(8):668-681. doi: 10.1016/j.tim.2020.03.016. Epub 2020 Apr 21.